{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:58:02Z","timestamp":1778183882849,"version":"3.51.4"},"reference-count":160,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.biocel.2009.03.015","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T04:34:10Z","timestamp":1238992450000},"page":"1989-2004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Gjumrakch","family":"Aliev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector H.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Walrafen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda E.","family":"Lipsitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Obrenovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludis","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-079X.2001.300201.x","article-title":"Melatonin, mitochondria, and cellular bioenergetics","volume":"30","author":"Acuna-Castroviejo","year":"2001","journal-title":"J Pineal Res"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9440(10)65588-5","article-title":"Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus","volume":"153","author":"Al-Abdulla","year":"1998","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3233\/JAD-2002-4607","article-title":"Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences?","volume":"4","author":"Aliev","year":"2002","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib4","first-page":"797","article-title":"Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis","volume":"13","author":"Aliev","year":"1998","journal-title":"Histol Histopathol"},{"issue":"3\u20134","key":"10.1016\/j.biocel.2009.03.015_bib5","first-page":"225","article-title":"Pathobiology of familial hypercholesterolemic atherosclerosis","volume":"36","author":"Aliev","year":"2004","journal-title":"J Submicrosc Cytol Pathol"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/mvre.1993.1035","article-title":"Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention","volume":"46","author":"Aliev","year":"1993","journal-title":"Microvasc Res"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/VHRM.S2608","article-title":"Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease","volume":"4","author":"Aliev","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1582-4934.2008.00324.x","article-title":"Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats","volume":"13","author":"Aliev","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.biocel.2009.03.015_bib9","unstructured":"Aliev, G., Liu, J., et al. (in press). Preventing cognitive decline in elderly demented\/depressed patients and in ApoE4 mouse as a model of human AD by feeding Acetyl-L-Carnitine and Lipoic Acid. In: International conference on Alzheimer's disease; July 11\u201316, 2009. Vienna, Austria. Control\/Tracking Number: 09-A-729-ALZ."},{"issue":"13","key":"10.1016\/j.biocel.2009.03.015_bib10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/138955708786369582","article-title":"Antioxidant therapy in Alzheimer's disease: theory and practice","volume":"8","author":"Aliev","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.biocel.2009.03.015_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2002.tb04798.x","article-title":"Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice","volume":"977","author":"Aliev","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.biocel.2009.03.015_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ncpcardio1295","article-title":"Stem cell niches as clinical targets: the future of anti-ischemic therapy?","volume":"5","author":"Aliev","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"26","key":"10.1016\/j.biocel.2009.03.015_bib13","article-title":"Neuronal mitochondrial abnormalities in yeast artificial chromosome (YAC) transgenic mice overexpressing amyloid precursor protein (APP)","volume":"30","author":"Aliev","year":"2000","journal-title":"Soc Neurosci Abs Book"},{"issue":"5\u20136","key":"10.1016\/j.biocel.2009.03.015_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mito.2004.07.018","article-title":"Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease","volume":"4","author":"Aliev","year":"2004","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/j.biocel.2009.03.015_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03033159","article-title":"Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease","volume":"5","author":"Aliev","year":"2003","journal-title":"Neurotox Res"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1750-3639.2002.tb00419.x","article-title":"The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease","volume":"12","author":"Aliev","year":"2002","journal-title":"Brain Pathol"},{"key":"10.1016\/j.biocel.2009.03.015_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jns.2004.11.040","article-title":"Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease","volume":"229\u2013230","author":"Aliyev","year":"2005","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2004-6202","article-title":"Mitochondrial decay, a major cause of aging, can be delayed","volume":"6","author":"Ames","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biocel.2009.03.015_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1196\/annals.1297.073","article-title":"Delaying the mitochondrial decay of aging","volume":"1019","author":"Ames","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2009.03.015_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1196\/annals.1320.010","article-title":"Delaying the mitochondrial decay of aging with acetylcarnitine","volume":"1033","author":"Ames","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2009.03.015_bib21","article-title":"Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests","author":"Bates","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.biocel.2009.03.015_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000113685","article-title":"Physiologic origins of age-related beta-amyloid deposition","volume":"5","author":"Beach","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","article-title":"Aging, energy, and oxidative stress in neurodegenerative diseases","volume":"38","author":"Beal","year":"1995","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1152\/physrev.1998.78.2.547","article-title":"The free radical theory of aging matures","volume":"78","author":"Beckman","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biocel.2009.03.015_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.1998.tb09897.x","article-title":"Mitochondrial aging: open questions","volume":"854","author":"Beckman","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"10.1016\/j.biocel.2009.03.015_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0027-5107(99)00007-X","article-title":"Endogenous oxidative damage of mtDNA","volume":"424","author":"Beckman","year":"1999","journal-title":"Mutat Res"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0197-4580(02)00050-7","article-title":"The amyloid hypothesis: let sleeping dogmas lie?","volume":"23","author":"Bishop","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0197-4580(02)00036-2","article-title":"Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities","volume":"23","author":"Blass","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2728(98)00165-0","article-title":"Mitochondrial involvement in Alzheimer's disease","volume":"1410","author":"Bonilla","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/153331750502000103","article-title":"Integrated treatment approach improves cognitive function in demented and clinically depressed patients","volume":"20","author":"Bragin","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","article-title":"Vascular risk factors for Alzheimer's disease: an epidemiologic perspective","volume":"21","author":"Breteler","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"14","key":"10.1016\/j.biocel.2009.03.015_bib32","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.10389","article-title":"Role of mitochondrial dysfunction in Alzheimer's disease","volume":"70","author":"Castellani","year":"2002","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib34","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1582-4934.2007.00130.x","article-title":"Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities","volume":"11","author":"Cedazo-Minguez","year":"2007","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/1043-6618(94)80053-7","article-title":"Endothelium as a therapeutical target in peripheral occlusive arterial diseases: consideration for pharmacological interventions","volume":"29","author":"Cirillo","year":"1994","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00005344-199212000-00018","article-title":"Effect of cloricromene during ischemia and reperfusion of rabbit hindlimb: evidence for an involvement of leukocytes in reperfusion-mediated tissue and vascular injury","volume":"20","author":"Cirillo","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib37","first-page":"454","article-title":"Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis","volume":"58","author":"Coria","year":"1988","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(01)02254-5","article-title":"In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation","volume":"900","author":"Cormier","year":"2001","journal-title":"Brain Res"},{"issue":"5134","key":"10.1016\/j.biocel.2009.03.015_bib39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0306-9877(98)90173-6","article-title":"Alzheimer's disease risk factors as related to cerebral blood flow: additional evidence","volume":"50","author":"Crawford","year":"1998","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","article-title":"Alzheimer neuropathologic alterations in aged cognitively normal subjects","volume":"58","author":"Davis","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biocel.2009.03.015_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.1997.tb48461.x","article-title":"Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies","volume":"826","author":"De Jong","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2009.03.015_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.1997.tb48462.x","article-title":"Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease","volume":"826","author":"de la Torre","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-4580(00)00111-1","article-title":"Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis","volume":"21","author":"de la Torre","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: nosological evidence","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-2002-4606","article-title":"Alzheimer's disease: how does it start?","volume":"4","author":"de la Torre","year":"2002","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1179\/016164104225016254","article-title":"Alzheimer's disease is a vasocognopathy: a new term to describe its nature","volume":"26","author":"de la Torre","year":"2004","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib49","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1179\/016164106X130362","article-title":"How do heart disease and stroke become risk factors for Alzheimer's disease?","volume":"28","author":"de la Torre","year":"2006","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-2008-14310","article-title":"Alzheimer's disease prevalence can be lowered with non-invasive testing","volume":"14","author":"de la Torre","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"3\u20134","key":"10.1016\/j.biocel.2009.03.015_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000113681","article-title":"Pathophysiology of neuronal energy crisis in Alzheimer's disease","volume":"5","author":"de la Torre","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-1998-1205","article-title":"Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease","volume":"1","author":"Etiene","year":"1998","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00004647-199904000-00001","article-title":"Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases","volume":"19","author":"Fiskum","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biocel.2009.03.015_bib56","first-page":"355","article-title":"Cerebral function in aging and Alzheimer's disease: the role of PET","volume":"42","author":"Friston","year":"1991","journal-title":"Electroencephalogr Clin Neurophysiol Suppl"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib57","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/01.CIR.92.6.1582","article-title":"Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein (a). Role of oxygen-derived radicals","volume":"92","author":"Galle","year":"1995","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biocel.2009.03.015_bib58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(05)70124-1","article-title":"Alzheimer's amyloid immunotherapy: quo vadis?","volume":"4","author":"Gandy","year":"2005","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.biocel.2009.03.015_bib59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrn2421","article-title":"Brain foods: the effects of nutrients on brain function","volume":"9","author":"Gomez-Pinilla","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"5 Pt 1","key":"10.1016\/j.biocel.2009.03.015_bib60","first-page":"G683","article-title":"Leukocyte adherence to venular endothelium during ischemia-reperfusion","volume":"257","author":"Granger","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biocel.2009.03.015_bib61","first-page":"42","article-title":"Dietary links to Alzheimer's disease","volume":"2","author":"Grant","year":"1997","journal-title":"Alzheimer's Dis Rev"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nm847","article-title":"Alzheimer disease's double-edged vaccine","volume":"9","author":"Greenberg","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.exer.2006.08.001","article-title":"Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease","volume":"84","author":"Hill","year":"2007","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.biocel.2009.03.015_bib64","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.biocel.2009.03.015_bib65","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-9525(01)02449-0","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"17","author":"Hock","year":"2001","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: the Rotterdam Study","volume":"22","author":"in\u2019t Veld","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004010050624","article-title":"Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels","volume":"93","author":"Iwamoto","year":"1997","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib68","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.38.6.909","article-title":"Longitudinal studies of regional cerebral metabolism in Alzheimer's disease","volume":"38","author":"Jagust","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.03.015_bib69","first-page":"435","article-title":"Production of transgenic mice with yeast artificial chromosomes","volume":"136","author":"Jakobovits","year":"2000","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.biocel.2009.03.015_bib70","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","article-title":"Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease","volume":"181","author":"Jana","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib71","first-page":"309","article-title":"Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease","volume":"135","author":"Joachim","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biocel.2009.03.015_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.1999.tb07821.x","article-title":"The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease","volume":"893","author":"Kalaria","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(00)00125-1","article-title":"The role of cerebral ischemia in Alzheimer's disease","volume":"21","author":"Kalaria","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.aje.a010000","article-title":"Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study","volume":"150","author":"Kalmijn","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib75","first-page":"1435","article-title":"The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease","volume":"137","author":"Kawai","year":"1990","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.biocel.2009.03.015_bib76","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nm0798-772","article-title":"Amyloid beta threads in the fabric of Alzheimer's disease","volume":"4","author":"Kisilevsky","year":"1998","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib77","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1006\/nbdi.2001.0446","article-title":"Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice","volume":"8","author":"Kulnane","year":"2001","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-3956(90)90050-Z","article-title":"Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features","volume":"24","author":"Kumar","year":"1990","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels","volume":"252","author":"Kuo","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib80","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2353\/ajpath.2006.060633","article-title":"Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!","volume":"169","author":"Lee","year":"2006","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4067\/S0716-97602004000200003","article-title":"Risk of dementia and alcohol and wine consumption: a review of recent results","volume":"37","author":"Letenneur","year":"2004","journal-title":"Biol Res"},{"issue":"42","key":"10.1016\/j.biocel.2009.03.015_bib82","doi-asserted-by":"crossref","first-page":"26091","DOI":"10.1074\/jbc.272.42.26091","article-title":"Amyloid-specific heparan sulfate from human liver and spleen","volume":"272","author":"Lindahl","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2009.03.015_bib83","article-title":"Targeting oxidative stress for neuroprotection","author":"Linseman","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biocel.2009.03.015_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.2002.tb02090.x","article-title":"Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites","volume":"959","author":"Liu","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib85","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.261709299","article-title":"Memory loss in old rats is associated with brain mitochondrial decay and RNA\/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and\/or R-alpha-lipoic acid","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2009.03.015_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1196\/annals.1320.011","article-title":"Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats","volume":"1033","author":"Liu","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib87","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1073\/pnas.261709098","article-title":"Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and\/or R-alpha-lipoic acid","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2009.03.015_bib88","article-title":"Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L: -carnitine","author":"Long","year":"2008","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib89","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1212\/WNL.51.6.1562","article-title":"Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease","volume":"51","author":"Lovell","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib90","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib91","doi-asserted-by":"crossref","first-page":"C719","DOI":"10.1152\/ajpcell.2001.280.4.C719","article-title":"Oxidant stress and endothelial cell dysfunction","volume":"280","author":"Lum","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"issue":"15","key":"10.1016\/j.biocel.2009.03.015_bib92","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib93","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1471-4159.2004.02884.x","article-title":"Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging","volume":"92","author":"Manczak","year":"2005","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/NMM:5:2:147","article-title":"Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage","volume":"5","author":"Manczak","year":"2004","journal-title":"Neuromol Med"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib95","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","article-title":"Oxidative alterations in Alzheimer's disease","volume":"9","author":"Markesbery","year":"1999","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000090868","article-title":"Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease","volume":"21","author":"Mas","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.33549\/physiolres.930000.49.11","article-title":"Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products","volume":"49","author":"Matz","year":"2000","journal-title":"Physiol Res"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02815160","article-title":"Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain","volume":"31","author":"Mecocci","year":"1997","journal-title":"Mol Chem Neuropathol"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.410360510","article-title":"Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease","volume":"36","author":"Mecocci","year":"1994","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410340416","article-title":"Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain","volume":"34","author":"Mecocci","year":"1993","journal-title":"Ann Neurol"},{"issue":"Pt 8","key":"10.1016\/j.biocel.2009.03.015_bib102","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/brain\/122.8.1519","article-title":"Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease","volume":"122","author":"Meguro","year":"1999","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.biocel.2009.03.015_bib103","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1096\/fj.07-8531com","article-title":"Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests","volume":"21","author":"Milgram","year":"2007","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib104","first-page":"1571","article-title":"Central nervous system lipoproteins in Alzheimer's disease","volume":"151","author":"Montine","year":"1997","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.jnen.0000240476.73532.b0","article-title":"Autophagocytosis of mitochondria is prominent in Alzheimer disease","volume":"66","author":"Moreira","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1\u20132","key":"10.1016\/j.biocel.2009.03.015_bib106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(99)01361-X","article-title":"Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls","volume":"828","author":"Natte","year":"1999","journal-title":"Brain Res"},{"issue":"37","key":"10.1016\/j.biocel.2009.03.015_bib107","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","article-title":"Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist","volume":"28","author":"Nicolakakis","year":"2008","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.biocel.2009.03.015_bib108","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biocel.2009.03.015_bib109","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.1999.tb07855.x","article-title":"Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome","volume":"893","author":"Nunomura","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib110","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease","volume":"19","author":"Nunomura","year":"1999","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03033333","article-title":"Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions","volume":"10","author":"Obrenovich","year":"2006","journal-title":"Neurotox Res"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib112","first-page":"197","article-title":"The amyloid peptide precursor in Alzheimer's disease","volume":"95","author":"Octave","year":"1995","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib113","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.STR.28.2.316","article-title":"Atrial fibrillation and dementia in a population-based study. The Rotterdam Study","volume":"28","author":"Ott","year":"1997","journal-title":"Stroke"},{"issue":"6985","key":"10.1016\/j.biocel.2009.03.015_bib114","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/bmj.310.6985.970","article-title":"Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study","volume":"310","author":"Ott","year":"1995","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.biocel.2009.03.015_bib115","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: the Rotterdam Study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.biocel.2009.03.015_bib116","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"4\u20135","key":"10.1016\/j.biocel.2009.03.015_bib117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0736-5748(00)00006-X","article-title":"Oxidative damage in Alzheimer's disease: the metabolic dimension","volume":"18","author":"Perry","year":"2000","journal-title":"Int J Dev Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.biocel.2009.03.015_bib118","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(98)00006-7","article-title":"Cerebrovascular muscle atrophy is a feature of Alzheimer's disease","volume":"791","author":"Perry","year":"1998","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1022457605436","article-title":"Regional membrane phospholipid alterations in Alzheimer's disease","volume":"23","author":"Prasad","year":"1998","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0006-291X(88)80486-8","article-title":"Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type","volume":"151","author":"Prelli","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/1028415021000033767","article-title":"Role of oxidative stress and antioxidants in neurodegenerative diseases","volume":"5","author":"Rao","year":"2002","journal-title":"Nutr Neurosci"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","article-title":"Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease","volume":"96","author":"Reddy","year":"2006","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib123","first-page":"31372","article-title":"Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics","volume":"2006","author":"Reddy","year":"2006","journal-title":"J Biomed Biotechnol"},{"issue":"10","key":"10.1016\/j.biocel.2009.03.015_bib124","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/ars.2007.1754","article-title":"Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons","volume":"9","author":"Reddy","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1582-4934.2007.00054.x","article-title":"Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins","volume":"11","author":"Reid","year":"2007","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib128","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.biocel.2009.03.015_bib129","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1212\/01.wnl.0000271395.29695.9a","article-title":"Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study","volume":"69","author":"Reitz","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.biocel.2009.03.015_bib130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1076-7460.2007.06696.x","article-title":"Cardiovascular risk factors for Alzheimer's disease","volume":"16","author":"Rosendorff","year":"2007","journal-title":"Am J Geriatr Cardiol"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-4886(95)90019-5","article-title":"On the metabolism of apolipoprotein E and the Alzheimer diseases","volume":"132","author":"Roses","year":"1995","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib132","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood.V87.5.1824.1824","article-title":"Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit","volume":"87","author":"Sala","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biocel.2009.03.015_bib133","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00005344-199410000-00015","article-title":"Functional depression of isolated perfused rat heart mediated by activated leukocytes: protective effect of cloricromene","volume":"24","author":"Salvatico","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"10.1016\/j.biocel.2009.03.015_bib134","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nn.2213","article-title":"Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease","volume":"11","author":"Sanchez-Mejia","year":"2008","journal-title":"Nat Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.biocel.2009.03.015_bib135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1006852306789","article-title":"The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases","volume":"174","author":"Schulz","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.biocel.2009.03.015_bib136","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.cb.10.110194.002105","article-title":"Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease","volume":"10","author":"Selkoe","year":"1994","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.biocel.2009.03.015_bib137","doi-asserted-by":"crossref","unstructured":"Shenk, J. C., Liu, J., et al. (2009). The effect of acetyl-L-Carnitine and Lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci. Epub ahead of Print.","DOI":"10.1016\/j.jns.2009.03.002"},{"issue":"8","key":"10.1016\/j.biocel.2009.03.015_bib138","first-page":"1044","article-title":"Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice","volume":"43","author":"Shi","year":"2002","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib139","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2796.1997.00197.x","article-title":"The emergence of mouse models of atherosclerosis and their relevance to clinical research","volume":"242","author":"Smith","year":"1997","journal-title":"J Intern Med"},{"issue":"6587","key":"10.1016\/j.biocel.2009.03.015_bib140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/382120b0","article-title":"Oxidative damage in Alzheimer's","volume":"382","author":"Smith","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2009.03.015_bib141","first-page":"58","article-title":"Commentary: diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease","volume":"2","author":"Smith","year":"1997","journal-title":"Alzheimer's Dis Rev"},{"issue":"8","key":"10.1016\/j.biocel.2009.03.015_bib142","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1523\/JNEUROSCI.17-08-02653.1997","article-title":"Widespread peroxynitrite-mediated damage in Alzheimer's disease","volume":"17","author":"Smith","year":"1997","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib143","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress and Alzheimer's disease","volume":"1501","author":"Smith","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer's disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"10.1016\/j.biocel.2009.03.015_bib145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02815203","article-title":"Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles","volume":"28","author":"Smith","year":"1996","journal-title":"Mol Chem Neuropathol"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib146","first-page":"63","article-title":"Is Alzheimer's a disease of oxidative stress?","volume":"1","author":"Smith","year":"1996","journal-title":"Alzheimer's Dis Rev"},{"issue":"12","key":"10.1016\/j.biocel.2009.03.015_bib147","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.biocel.2009.03.015_bib148","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0891-5849(98)00119-1","article-title":"Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease","volume":"25","author":"Smith","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biocel.2009.03.015_bib149","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1997.tb48466.x","article-title":"Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?","volume":"826","author":"Sparks","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2009.03.015_bib150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1749-6632.2000.tb06384.x","article-title":"Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations","volume":"903","author":"Sparks","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib151","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/00005344-199506000-00008","article-title":"Differences in onset of impaired endothelial responses and in effects of vitamin E in the hypercholesterolemic rabbit carotid and renal arteries","volume":"25","author":"Stewart-Lee","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib152","first-page":"734","article-title":"A morphometric study of the blood-brain barrier in Alzheimer's disease","volume":"67","author":"Stewart","year":"1992","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.biocel.2009.03.015_bib153","first-page":"761","article-title":"Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls","volume":"62","author":"Tagliavini","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.biocel.2009.03.015_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresrev.2008.07.007","article-title":"New insights into brain BDNF function in normal aging and Alzheimer disease","author":"Tapia-Arancibia","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.biocel.2009.03.015_bib155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2000.tb06353.x","article-title":"Distribution of amyloid beta 42 in relation to the cerebral microvasculature in an elderly cohort with Alzheimer's disease","volume":"903","author":"Thomas","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.biocel.2009.03.015_bib156","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21073","article-title":"Atherosclerosis and risk for dementia","volume":"61","author":"van Oijen","year":"2007","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.biocel.2009.03.015_bib157","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","article-title":"Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia","volume":"36","author":"van Oijen","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.biocel.2009.03.015_bib158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-109-1-41","article-title":"Brain amyloid and Alzheimer disease","volume":"109","author":"Vinters","year":"1988","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.biocel.2009.03.015_bib159","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/scientificamerican0897-40","article-title":"Mitochondrial DNA in aging and disease","volume":"277","author":"Wallace","year":"1997","journal-title":"Sci Am"},{"issue":"5407","key":"10.1016\/j.biocel.2009.03.015_bib160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:36:15Z","timestamp":1761201375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272509001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":160,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1357272509001198"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2009.03.015","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2009.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}